| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.91B | $2.54B | $2.15B |
| YoY Revenue Growth % | +14.7% | +17.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $598.0M | $620.0M | $808.0M |
| Operating Margin % | 20.5% | 24.4% | 37.5% |
| Net Income (GAAP) | $363.0M | $376.0M | $564.0M |
| EBITDA (Normalized) | $855.6M | $824.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $865.0M | $610.0M | $653.0M |
| Capital Expenditures (CapEx) | $322.0M | $255.0M | — |
| Free Cash Flow (FCF) | $543.0M | $355.0M | $653.0M |
| FCF Margin % | 18.7% | 14.0% | 30.3% |
| Return on Invested Capital (ROIC %) | 9.8% | 11.4% | — |
| Cash & Short-Term Equivalents | $132.0M | $372.0M | — |
| Total Debt (Short + Long Term) | $1.28B | $1.13B | — |
| Total Stockholders' Equity | $3.67B | $3.54B | — |